Stonebrook Private’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.62M Sell
14,252
-54
-0.4% -$12.6K 0.66% 32
2026
Q1
$3.5M Buy
14,306
+136
+1% +$31.7K 0.74% 28
2025
Q4
$2.93M Sell
14,170
-9,931
-41% -$1.96M 0.61% 37
2025
Q3
$4.47M Buy
24,101
+640
+3% +$110K 0.97% 26
2025
Q2
$3.58M Buy
23,461
+391
+2% +$60.1K 0.84% 24
2025
Q1
$3.83M Buy
23,070
+668
+3% +$105K 0.99% 25
2024
Q4
$3.24M Sell
22,402
-2,057
-8% -$319K 0.85% 27
2024
Q3
$3.96M Sell
24,459
-112
-0.5% -$17.8K 1.05% 26
2024
Q2
$3.59M Sell
24,571
-108
-0.4% -$16.1K 1.03% 27
2024
Q1
$3.9M Buy
24,679
+1,820
+8% +$290K 1.14% 27
2023
Q4
$3.58M Buy
+22,859
New +$3.51M 1.2% 27

Other funds holding JNJ

Stonebrook Private's JNJ Position: Q2 2026 in Review

Stonebrook Private reduced its Johnson & Johnson (JNJ) stake by 0.38% in Q2 2026, selling an estimated $12.6K and leaving 14,252 shares worth $3.62M. The position accounts for 0.66% of the portfolio, ranked #32.

Stonebrook Private first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. The position peaked at $4.47M in Q3 2025. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Stonebrook Private held 14,252 shares of Johnson & Johnson worth $3.62M as of Q2 2026.
  • Stonebrook Private sold 54 Johnson & Johnson shares in Q2 2026, an estimated $12.6K.
  • Johnson & Johnson made up 0.66% of Stonebrook Private's portfolio in Q2 2026, its #32 holding.
  • Stonebrook Private first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • Stonebrook Private's Johnson & Johnson position peaked at $4.47M in Q3 2025.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Stonebrook Private's 13F filing for Q2 2026, filed 14 Aug 2026.